CD4+ T cell activation, function, and metabolism are inhibited by very low concentrations of DMSO

This abstract has open access
Abstract Summary

Dimethyl sulfoxide (DMSO) is a polar organic solvent ubiquitously used in a wide range of biological applications and research areas. DMSO is toxic for cells at high concentrations, but its toxicity at low concentrations is insufficiently investigated. DMSO is routinely used as a cryoprotectant for long term cell freezing as well as to dissolve peptides and drugs for immune cell functional assays with concentrations up to 1% of DMSO not uncommon in in vitro T cell assays.

Human CD4+ T cell activation, cytokine production, proliferation, and metabolism were investigated after stimulation in the presence of DMSO at concentrations from 0.01% to 1%.

Polyclonal activation of CD4+ T cells as defined by the expression of CD69, CD25 and CD154 was inhibited by DMSO already at a concentration of 0.25%. The frequencies of IL-21+, IL-4+, and IL-22+ T cells following polyclonal activation were variably inhibited by DMSO from concentrations ranging from 0.25% to 1%, whereas IFNg+ cells were unaffected up to a concentration of 1% DMSO. CD4+ T cell proliferation after anti-CD3 or antigen stimulation was inhibited by 0.5% DMSO and completely inhibited by 1% DMSO. Glucose uptake was inhibited at 1% DMSO, but only minor effects on cell respiration were observed in the presence of DMSO up to 1%.

The present study revealed that DMSO affects T cell responses at very low concentrations. Furthermore, T cell functional assays were affected by different DMSO concentration thresholds. We, therefore, urge care when adding DMSO-containing preparations to T cell cultures.

Submission ID :
IDS24142
Submission Type
Abstract Topics
Institute for Diabetes and Obesity, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany
Institute for Diabetes and Obesity, Helmholtz Zentrum Munich, Germany
Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany
CRTD-DFG Center for Regenerative Therapies Dresden, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany
Institute for Diabetes and Obesity, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany
CRTD Center for Regenerative Therapies Dresden

Abstracts With Same Type

Submission ID
Submission Title
Submission Topic
Submission Type
Primary Author
4 visits

KEY DATES

Event dates:
Thursday 25 October - Monday 29 October 2018

Abstract submission deadline:
Monday 14 May 2018

Abstract notification:
July 2018

Early registration deadline:
Monday 3 September 2018

Registration deadline:
Monday 15 October 2018

Contact
British Society for Immunology
+44 (0)20 3019 5901
congress@immunology.org